BRPI0914225A2 - preparação de formas galênicas de liberação controlada de relaxantes do músculo-esquelético - Google Patents

preparação de formas galênicas de liberação controlada de relaxantes do músculo-esquelético

Info

Publication number
BRPI0914225A2
BRPI0914225A2 BRPI0914225A BRPI0914225A BRPI0914225A2 BR PI0914225 A2 BRPI0914225 A2 BR PI0914225A2 BR PI0914225 A BRPI0914225 A BR PI0914225A BR PI0914225 A BRPI0914225 A BR PI0914225A BR PI0914225 A2 BRPI0914225 A2 BR PI0914225A2
Authority
BR
Brazil
Prior art keywords
preparation
controlled release
skeletal muscle
muscle relaxants
galenic forms
Prior art date
Application number
BRPI0914225A
Other languages
English (en)
Inventor
Venkatesh Gopi
clevenger James
Grinstead Timothy
Original Assignee
Eurand Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41434443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0914225(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eurand Inc filed Critical Eurand Inc
Publication of BRPI0914225A2 publication Critical patent/BRPI0914225A2/pt
Publication of BRPI0914225A8 publication Critical patent/BRPI0914225A8/pt
Publication of BRPI0914225B1 publication Critical patent/BRPI0914225B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0914225-8A 2008-06-20 2009-06-18 Método de preparação de uma composição farmacêutica de formas galênicas de liberação controlada de relaxantes do músculo-esquelético BRPI0914225B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7446408P 2008-06-20 2008-06-20
US61/074,464 2008-06-20
PCT/US2009/047807 WO2009155426A1 (en) 2008-06-20 2009-06-18 Preparation of controlled release skeletal muscle relaxant dosage forms

Publications (3)

Publication Number Publication Date
BRPI0914225A2 true BRPI0914225A2 (pt) 2017-11-07
BRPI0914225A8 BRPI0914225A8 (pt) 2018-02-06
BRPI0914225B1 BRPI0914225B1 (pt) 2021-08-31

Family

ID=41434443

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914225-8A BRPI0914225B1 (pt) 2008-06-20 2009-06-18 Método de preparação de uma composição farmacêutica de formas galênicas de liberação controlada de relaxantes do músculo-esquelético

Country Status (29)

Country Link
US (3) US20090148532A1 (pt)
EP (1) EP2303020B1 (pt)
JP (1) JP5636364B2 (pt)
KR (1) KR101451823B1 (pt)
CN (2) CN106860430A (pt)
AR (2) AR072267A1 (pt)
AU (1) AU2009259993B2 (pt)
BR (1) BRPI0914225B1 (pt)
CA (1) CA2727935C (pt)
CL (1) CL2009001447A1 (pt)
CO (1) CO6300903A2 (pt)
CR (1) CR11864A (pt)
CY (1) CY1118878T1 (pt)
DK (1) DK2303020T3 (pt)
ES (1) ES2625485T3 (pt)
HU (1) HUE032182T2 (pt)
IL (1) IL209997A0 (pt)
MX (1) MX2010013760A (pt)
MY (2) MY153712A (pt)
NZ (1) NZ589856A (pt)
PL (1) PL2303020T3 (pt)
PT (1) PT2303020T (pt)
PY (1) PY09020965A (pt)
RU (1) RU2540494C2 (pt)
SG (1) SG193816A1 (pt)
TW (2) TWI458480B (pt)
UY (1) UY31928A (pt)
WO (1) WO2009155426A1 (pt)
ZA (2) ZA201009083B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
US9498440B2 (en) 2009-05-22 2016-11-22 Inventia Healthcare Private Limited Extended release pharmaceutical compositions
SMT201700578T1 (it) * 2009-11-20 2018-01-11 Tonix Pharma Holdings Ltd Metodo e composizioni per trattare i sintomi associati al disturbo da stress post-traumatico usando ciclobenzaprina
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
US20150086626A1 (en) * 2012-04-17 2015-03-26 Mylan, Inc Stable dosage forms of skeletal muscle relaxants with extended release coating
RS63822B1 (sr) * 2012-06-15 2023-01-31 Tonix Pharma Holdings Ltd Kompozicije i postupci za transmukoznu apsorpciju
SMT202400324T1 (it) 2013-03-15 2024-11-15 Tonix Pharma Ltd Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo
MY186047A (en) 2014-09-18 2021-06-17 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
EA201992116A1 (ru) * 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
MX2020006140A (es) 2017-12-11 2020-08-13 Tonix Pharma Holdings Ltd Tratamiento con ciclobenzaprina para la agitacion, psicosis y deterioro cognitivo en la demencia y enfermedades neurodegenerativas.
CN109381446A (zh) * 2018-11-26 2019-02-26 正大制药（青岛）有限公司 一种盐酸环苯扎林缓释胶囊
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法
CN114432266B (zh) * 2021-12-23 2023-03-10 南通联亚药业股份有限公司 一种稳定的盐酸环苯扎林缓释胶囊

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882246A (en) * 1971-05-21 1975-05-06 Merck & Co Inc Treatment of skeletal muscle disorders with cyclobenzaprine
US4337582A (en) * 1980-09-30 1982-07-06 Airco, Inc. Methods for controlling vapor concentrations in an atmosphere
US4685918A (en) 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump
US5047258A (en) 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
WO2001019901A2 (en) * 1999-09-14 2001-03-22 Smithkline Beecham Corporation Process for making aqueous coated beadlets
US6576702B2 (en) 2000-07-20 2003-06-10 Noveon Ip Holdings Corp. Plasticized waterborne polyurethane dispersions and manufacturing process
EP1499289B1 (en) 2002-03-29 2008-07-23 Alza Corporation Volume efficient controlled release dosage form
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
JP2007509155A (ja) 2003-10-21 2007-04-12 アルファーマ インコーポレイテッド クエチアピンを含有する薬剤
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
WO2006023347A1 (en) 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060263429A1 (en) * 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
MX2008012260A (es) * 2006-03-24 2008-10-07 Panacea Biotec Ltd Composiciones antibioticas de liberacion modificada y procedimiento para su produccion.
US20090148532A1 (en) 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms

Also Published As

Publication number Publication date
CO6300903A2 (es) 2011-07-21
EP2303020A4 (en) 2013-12-04
NZ589856A (en) 2012-06-29
CA2727935C (en) 2017-05-30
PY09020965A (es) 2014-11-03
CN102065691A (zh) 2011-05-18
CR11864A (es) 2011-05-16
RU2011101918A (ru) 2012-07-27
MY153712A (en) 2015-03-13
TW201503915A (zh) 2015-02-01
DK2303020T3 (en) 2017-05-01
WO2009155426A1 (en) 2009-12-23
MX2010013760A (es) 2011-03-29
CA2727935A1 (en) 2009-12-23
PL2303020T3 (pl) 2017-08-31
RU2540494C2 (ru) 2015-02-10
CY1118878T1 (el) 2018-01-10
EP2303020B1 (en) 2017-02-22
HUE032182T2 (en) 2017-09-28
TWI458480B (zh) 2014-11-01
AR113877A2 (es) 2020-06-24
KR20110025654A (ko) 2011-03-10
SG193816A1 (en) 2013-10-30
TW201004615A (en) 2010-02-01
JP5636364B2 (ja) 2014-12-03
IL209997A0 (en) 2011-02-28
BRPI0914225B1 (pt) 2021-08-31
MY173408A (en) 2020-01-22
ES2625485T3 (es) 2017-07-19
BRPI0914225A8 (pt) 2018-02-06
US8137734B2 (en) 2012-03-20
PT2303020T (pt) 2017-06-02
ZA201109534B (en) 2013-10-30
JP2011525188A (ja) 2011-09-15
AR072267A1 (es) 2010-08-18
US20090148532A1 (en) 2009-06-11
US20120196028A1 (en) 2012-08-02
CL2009001447A1 (es) 2009-08-21
EP2303020A1 (en) 2011-04-06
AU2009259993A1 (en) 2009-12-23
US20100098832A1 (en) 2010-04-22
AU2009259993B2 (en) 2013-10-31
KR101451823B1 (ko) 2014-10-16
UY31928A (es) 2010-01-29
CN106860430A (zh) 2017-06-20
ZA201009083B (en) 2012-03-28

Similar Documents

Publication Publication Date Title
BRPI0914225A2 (pt) preparação de formas galênicas de liberação controlada de relaxantes do músculo-esquelético
IL208858A (en) Formulations containing fats, methods of selecting and manufacturing and using them
EP2242437A4 (en) FACETTENFIXIERPROTHESE
EP3542792C0 (en) CONTROLLED RELEASE 25-HYDROXYVITAMIN D
BRPI0821732A2 (pt) Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
PT2376533T (pt) Formulação de anticorpos
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0912213A2 (pt) preparação cosmética
BRPI0812209A2 (pt) Partícula de liberação contendo agente de benefício
BRPI0908596A2 (pt) formulação e composição farmacêutica de liberação prolongada
DK2621523T3 (da) Fremgangsmåder til fremstilling af autoimmune sygdomme ved anvendelse af biokompatible bioabsorberbare nanokugler
EP2271347A4 (en) ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
EP2155147A4 (en) ALOE PREPARATION FOR SKIN IMPROVEMENT
UY33094A (es) Procedimiento para la preparacion de dronedarona
BRPI0922804A2 (pt) formas de dosagem sólidas de bendamustina
BRPI0905954A2 (pt) Âncora para manipulação de elementos de construção compreendendo ramos divergentes
BRPI0916694A2 (pt) combinação antineoplásicas de 4-anilino-3-cianoquinolinas e capecitabina
DOP2009000144A (es) Composicion de liberacion sostenida y metodos para producir la misma
BRPI0917707A2 (pt) composições biocidas potencializadas e métodos de uso
BRPI0913337A2 (pt) liberação pulsátil de valsartan
BRPI0912428A2 (pt) formulação farmacêutica sólida de liberação retardada
BRPI0909189A2 (pt) combinações sinergísticas de 5'-metiltioadenosina
BRPI0811132A2 (pt) Preparação de catalisadores de paládio-ouro
ZA201102518B (en) Modified release formulation and methods of use
ZA200904939B (en) Extended release formulation of nevirapine

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: APTALIS PHARMATECH, INC. (US)

B25D Requested change of name of applicant approved

Owner name: ADARE PHARMACEUTICALS, INC. (US)

B25G Requested change of headquarter approved

Owner name: ADARE PHARMACEUTICALS, INC. (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/06/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.